BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: IJzerman AP, Jacobson KA, Müller CE, Cronstein BN, Cunha RA. International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update. Pharmacol Rev 2022;74:340-72. [PMID: 35302044 DOI: 10.1124/pharmrev.121.000445] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Sluyter R, Sophocleous RA, Stokes L. P2X receptors: Insights from the study of the domestic dog. Neuropharmacology 2022. [DOI: 10.1016/j.neuropharm.2022.109358] [Reference Citation Analysis]
2 Vlajkovic SM, Thorne PR. Purinergic Signalling in the Cochlea. IJMS 2022;23:14874. [DOI: 10.3390/ijms232314874] [Reference Citation Analysis]
3 Ferré S, Sarasola LI, Quiroz C, Ciruela F. Presynaptic adenosine receptor heteromers as key modulators of glutamatergic and dopaminergic neurotransmission in the striatum. Neuropharmacology 2022. [DOI: 10.1016/j.neuropharm.2022.109329] [Reference Citation Analysis]
4 Rikitake M, Notake S, Kurokawa K, Hata J, Seki F, Komaki Y, Oshiro H, Kawaguchi N, Haga Y, Yoshimaru D, Ito K, Okano HJ. Effects of chronic caffeine intake and withdrawal on neural activity assessed via resting-state functional magnetic resonance imaging in mice. Heliyon 2022. [DOI: 10.1016/j.heliyon.2022.e11714] [Reference Citation Analysis]
5 Asgharkhah E, Saghaeian Jazi M, Asadi J, Jafari SM. Gene expression pattern of adenosine receptors in lung tumors. Cancer Reports 2022. [DOI: 10.1002/cnr2.1747] [Reference Citation Analysis]
6 Beerkens BLH, Koç Ç, Liu R, Florea BI, Le Dévédec SE, Heitman LH, Ijzerman AP, van der Es D. A Chemical Biological Approach to Study G Protein-Coupled Receptors: Labeling the Adenosine A1 Receptor Using an Electrophilic Covalent Probe. ACS Chem Biol 2022. [DOI: 10.1021/acschembio.2c00589] [Reference Citation Analysis]
7 Pasquini S, Contri C, Cappello M, Borea PA, Varani K, Vincenzi F. Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications. Front Pharmacol 2022;13:1030895. [DOI: 10.3389/fphar.2022.1030895] [Reference Citation Analysis]
8 Matsuoka I, Yoshida K, Ito MA. Purinergic regulation of mast cell function: P2X4 receptor-mediated enhancement of allergic responses. J Pharmacol Sci 2022;150:94-9. [PMID: 36055757 DOI: 10.1016/j.jphs.2022.07.005] [Reference Citation Analysis]
9 Zhao YF, Verkhratsky A, Tang Y, Illes P. Astrocytes and major depression: The purinergic avenue. Neuropharmacology 2022;220:109252. [PMID: 36122663 DOI: 10.1016/j.neuropharm.2022.109252] [Reference Citation Analysis]
10 Valada P, Alçada-Morais S, Cunha RA, Lopes JP. Thebromine Targets Adenosine Receptors to Control Hippocampal Neuronal Function and Damage. Int J Mol Sci 2022;23:10510. [PMID: 36142422 DOI: 10.3390/ijms231810510] [Reference Citation Analysis]
11 Qiu W, Zhao W, Zhang L, Wang H, Li N, Chen K, Zhang H, Wang Y. A Solid–Liquid Composite Lubricating “Nano‐Snowboard” for Long‐Acting Treatment of Osteoarthritis. Adv Funct Materials. [DOI: 10.1002/adfm.202208189] [Reference Citation Analysis]
12 Passarella D, Ronci M, Di Liberto V, Zuccarini M, Mudò G, Porcile C, Frinchi M, Di Iorio P, Ulrich H, Russo C. Bidirectional Control between Cholesterol Shuttle and Purine Signal at the Central Nervous System. IJMS 2022;23:8683. [DOI: 10.3390/ijms23158683] [Reference Citation Analysis]
13 Ahmadi P, Yan M, Bauche A, Smeets R, Müller CE, Koch-nolte F, Haag F, Fliegert R, Kluwe L, Wiesch JSZ, Hartjen P. Human dental pulp cells modulate CD8+ T cell proliferation and efficiently degrade extracellular ATP to adenosine in vitro. Cellular Immunology 2022. [DOI: 10.1016/j.cellimm.2022.104589] [Reference Citation Analysis]
14 Fisher CL, Fallot LB, Wan TC, Keyes RF, Suresh RR, Rothwell AC, Gao Z, Mccorvy JD, Smith BC, Jacobson KA, Auchampach JA. Characterization of Dual-Acting A 3 Adenosine Receptor Positive Allosteric Modulators That Preferentially Enhance Adenosine-Induced Gα i3 and Gα oA Isoprotein Activation. ACS Pharmacol Transl Sci . [DOI: 10.1021/acsptsci.2c00076] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Yegutkin GG, Boison D. ATP and Adenosine Metabolism in Cancer: Exploitation for Therapeutic Gain. Pharmacol Rev 2022;74:797-822. [PMID: 35738682 DOI: 10.1124/pharmrev.121.000528] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Temirak A, Schlegel JG, Voss JH, Vaaßen VJ, Vielmuth C, Claff T, Müller CE. Irreversible Antagonists for the Adenosine A2B Receptor. Molecules 2022;27:3792. [PMID: 35744918 DOI: 10.3390/molecules27123792] [Reference Citation Analysis]
17 Mori A, Chen JF, Uchida S, Durlach C, King SM, Jenner P. The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson's Disease. Molecules 2022;27:2366. [PMID: 35408767 DOI: 10.3390/molecules27072366] [Cited by in F6Publishing: 1] [Reference Citation Analysis]